Mesoblast Limited
MEOBF
$1.37
-$0.25-15.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.97M | -23.97M | -27.71M | -27.71M | -16.27M |
| Total Depreciation and Amortization | 1.04M | 1.04M | 1.11M | 1.11M | 1.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.79M | 12.79M | 14.65M | 14.65M | 4.08M |
| Change in Net Operating Assets | -195.00K | -195.00K | 1.00M | 1.00M | -2.32M |
| Cash from Operations | -10.33M | -10.33M | -10.94M | -10.94M | -13.29M |
| Capital Expenditure | -53.00K | -53.00K | -38.50K | -38.50K | -97.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 366.50K | 366.50K | 34.00K | 34.00K | 53.00K |
| Cash from Investing | 313.50K | 313.50K | -4.50K | -4.50K | -44.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.79M | -1.79M | -5.69M | -5.69M | -1.07M |
| Issuance of Common Stock | 670.50K | 670.50K | 12.85M | 12.85M | 19.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.01M | -1.01M | -2.83M | -2.83M | -2.98M |
| Cash from Financing | -2.13M | -2.13M | 4.33M | 4.33M | 15.80M |
| Foreign Exchange rate Adjustments | -319.50K | -319.50K | -675.50K | -675.50K | 648.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.47M | -12.47M | -7.30M | -7.30M | 3.12M |
